We’re excited to announce that Akebia Therapeutics and Keryx Biopharmaceuticals have merged, creating a fully integrated company focused on the development and commercialization of therapeutics for patients with kidney disease. The combined company is called Akebia. To learn about the merger, please read our press release. Read about the merger here »
So What is HIF?
HIF helps the body to adapt to conditions of low oxygen, similar to what is experienced at moderate altitude. Learn more about the potential therapeutic value of HIF.
The Science of High Altitude
We’re Exploring the Link Between Hypoxia and Treatment of Serious Diseases.
